EFFECT OF AN EYE MASK ON MIDAZOLAM REQUIREMENT FOR SEDATION DURING SPINAL ANAESTHESIA
Main Article Content
Keywords
Midazolam, Eye mask Sedation, Spinal anaesthesia
Abstract
Background : Anxiety during spinal anesthesia can exacerbate hemodynamic instability. Midazolam is commonly used for sedation, but external factors like bright lights and a busy operating environment may increase patient discomfort and sedative requirements. This study evaluates whether the use of an eye mask can reduce midazolam requirements during spinal anesthesia.
Study Population:Adult age group between 18 year to 80 years divide randomly among two group ,one masked group and other unmasked group.
Aims: To assess the effect of eye mask use on midazolam requirements and sedation quality during spinal anesthesia.
Methods: After intrathecal injection of 10–14 mg of 0.5% hyperbaric bupivacaine, patients were positioned supine. Sensory block was confirmed at 20 minutes. Sedation was assessed using the Modified Observer’s Assessment of Alertness/Sedation (MOAA/S) scale after administering 1 mg IV midazolam every 5 minutes until a score of 3 was reached or up to 35 minutes. Total dose and time to reach MOAA/S score 3 were recorded
Result: The finding was the significantly lower mean midazolam requirement in the masked group (2.06 ± 0.55 mg) compared to the unmasked group (3.14 ± 0.59 mg), with a highly significant p-value (<
0.001).Sedation onset time was notably shorter in the masked group (9.1 ± 2.98 min) compared to the unmasked group (13.3 ± 3.53 min), again statistically significant (p < 0.001).
Conclusion:By masking the external factors the requirement of midazolam shows significant decrease in spinal anaesthesia block compare to those without face mask.
References
2. Hogan QH, Bridenbaugh PO. Neuraxial Anaesthesia: Principles and Practice. Philadelphia: Saunders; 1998.
3. Hadzic A, editor. Textbook of Regional Anaesthesia and Acute Pain Management. 2nd ed. New York: McGraw Hill; 2017.
4. Sites BD, Chan VW, Neal JM. Ultrasound in Regional Anaesthesia. Anaesthesiology Analogue. 2010;110(2):421–427.
5. Miller RD, Cohen NH, Eriksson LI, Fleisher LA, Wiener-Kronish JP, Young WL. Miller‟s Anaesthesia. 9th ed. Philadelphia: Elsevier; 2020.
6. Chisholm MF, Owen H. Patient anxiety during regional anaesthesia. Anaesthesia Intensive Care. 2008;36(5):682–692.
7. 7.Dundee JW, Halliday NJ, Harper KW, Brogden RN. Midazolam. A review of its pharmacological properties and therapeutic use. Drugs. 1984;28(6):519–543.
8. Reves JG, Fragen RJ, Vinik HR, Greenblatt DJ. Midazolam:pharmacology and uses. Anaesthesiology. 1985;62(3):310–324.
9. Dundee JW, Collier PS. Midazolam in clinical anaesthesia. Br J Anaesthesiology. 1980;52(9):849–857.
10. Mandema JW, Tuk B, van Steveninck AL, Breimer DD, Cohen AF, Danhof M. Pharmacokinetic and pharmacodynamic modelling of midazolam effects on plasma cortisol and sedation. Br J Clin Pharmacology. 1992;33(3):275–285.
11. Greenblatt DJ, Abernethy DR, Locniskar A, Harmatz JS, Limjuco
12. RA, Shader RI. Effect of age, gender, and obesity on midazolam kinetics. Anaesthesiology. 1984;61(1):27–35
13. Olsen RW, Sieghart W. GABA A receptors: subtypes provide diversity of function and pharmacology. Neuropharmacology. 2009;56(1):141–148.
14. Sigel E, Steinmann ME. Structure, function, and modulation of GABA A receptors. J Biol Chem. 2012;287(48):40224–40231.
15. Vuyk J, Sitsen E, Reekers M. Intravenous anaesthetics. In: Miller RD, Eriksson LI, Fleisher LA, et al., editors. Miller‟s Anaesthesia. 8th ed. Philadelphia: Elsevier Saunders; 2015. P. 821–863.
16. Fragen RJ, Avram MJ, Caldwell N. Midazolam: pharmacokinetics and pharmacodynamics. Anaesthesia Analogue. 1983;62(6):537–542.
17. McClure JH. Respiratory depression and midazolam. Anaesthesia. 1987;42(6):576–577.
18. Bailey PL, Pace NL, Ashburn MA, Moll JW, East KA, Stanley TH. Frequent hypoxemia and apnoea after sedation with midazolam and fentanyl. Anaesthesiology. 1990;73(5):826–830.
19. Bonnet F, Larousse C, Saada M, Rostaing S, Aubrun F. Effect of spinal anaesthesia on the hypnotic requirement of midazolam. Br J Anaesthesiology. 1990;64(3):346–348.
20. Fassoulaki A, Melemeni A, Paraskeva A. Hypnotic requirements during spinal anaesthesia. European J Anaesthesiology. 2000;17(7):453–457.
21. Borgeat A, Wilder-Smith OH, Saiah M, Rifat K. Sub hypnotic doses of midazolam and fentanyl augment the respiratory depressant effect of propofol. Anaesthesia Analogue. 1993;77(3):499–505.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr Samreen Azim
Resident Department of anesthesia SKIMS Soura Srinagar
Dr anjum rashid
Resident Department of anesthesia SKIMS Soura Srinagar
Dr mohd azam lone
Resident Department of Medicine SKIMS SOURA
Dr Aaqib Suhail Mir
Resident Department of anesthesia SKIMS Soura Srinagar
Dr Basharat Ahad
Professor Department of anesthesia SKIMS Soura Srinagar